Physician profile
Danny Le
NPI 1871919738
$1,278.46
in general payments reported to CMS, 2019-2025
12 companies · $236 in 2025
The $236 reported for 2025 was more than what 91% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.12 · 2022: $122 · 2023: $521 · 2024: $387 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $216.86 | 2023-2024 | Hemosphere |
| Fisher & Paykel Healthcare INC | $159.78 | 2023-2025 | Fisher & Paykel Healthcare |
| Abbott Laboratories | $148.37 | 2023 | Freestyle Libre 3 |
| Aimmune Therapeutics, INC. | $124.99 | 2024 | |
| Glaxosmithkline, LLC. | $122.95 | 2025 | Arexvy |
| E.R. Squibb & Sons, L.L.C. | $121.82 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $101.35 | 2023 | Andexxa |
| Ucb, INC. | $100.04 | 2024 | Nayzilam |
| Merck Sharp & Dohme LLC | $95.63 | 2023-2025 | Bridion |
| Silk Road Medical, INC. | $47.33 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Pacira Pharmaceuticals Incorporated | $26.22 | 2025 | Exparel |
| Chiesi USA, INC. | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.